[1] |
国家食品药品监督管理总局. 药品不良反应报告和监测管理办法[R/OL]. (2011-05-04) [2017-03-01]. .
|
|
China Food and Drug Administraion. Measures for the reporting and monitoring of adverse drug reactions[R/OL]. (2011-05-04) [2017-03-01]. .
|
[2] |
陈志高. 浅谈建立药品不良反应监测的意义和存在问题及改进措施[J]. 江苏药学与临床研究, 2005, 13(4):47.
|
|
Chen ZG.The meaning of adverse drug reaction report sys-tem and the measures for present problems of adverse drug reaction monitoring[J]. Jiangsu Pharm Clin Res, 2005, 13(4):47.
|
[3] |
黄道秋. 110例药物不良反应报告分析[J]. 中国新药杂志, 2006, 15(12):1014.
|
|
Huang DQ.Analysis of 110 incidences of adverse drug reac-tions[J]. Chin J New Drug, 2006, 15(12):1014.
|
[4] |
Ratschko M, Fenner T, Lankisch PG.The role of antibiotic prophylaxis in the treatment of acute pancreatitis[J]. Gas-troenterol Clin North Am, 1999, 28(3):641-659.
|
[5] |
王晓瑜, 杜文民, 王宏敏, 等. 药品不良反应报告中存在的问题及改进建议[J]. 上海医药, 2006, 27(5):215.
|
|
Wang XY, Du WM, Wang HM, et al.Existing problems in adverse drug reaction reports and corresponding suggestions for improvement[J]. Shanghai Med Pharm J, 2006, 27(5):215.
|
[6] |
梁莉, 王爱丽, 倪梁朝, 等. 172例药物不良反应报告分析及其预防措施的探讨[J]. 国际医药卫生导报, 2006, 12(4):74.
|
|
Liang L, Wang AL, Ni LZ, et al.Analysis of 172 samples reported and discussion about the methods of prevention with adverse drug reactions[J]. Int Med Health Guid New, 2006, 12(4):74.
|
[7] |
Alomar MJ.Factors affecting the development of adverse drug reactions (Review article)[J]. Saudi Pharm J, 2014, 22(2):83-94.
|
[8] |
刘晓琰, 曹惠明, 沈金芳. 我院完善药品不良反应监测与报告体系的实践与体会[J]. 中国药房, 2007, 18(11):862-863.
|
|
Liu XY, Cao HM, Shen JF.Improving adverse drug reac-tion monitoring and reporting system in our hospital: prac-tice and experience[J]. Chin Pharm, 2007, 18(11):862-863.
|
[9] |
赵静, 王松林. 关于我国药品不良反应报告制度的思考[J]. 中国新药杂志, 2008, 17(8):642-644.
|
|
Zhao J, Wang SL.Pondering on adverse drug reactions reporting system[J]. Chin J New Drug, 2008, 17(8):642-644.
|